Best Urolithin A for GLP-1 Users (Muscle Support)

Reviewed by SOMA HEALTH's Medical Research Team

On a GLP-1 weight program, the scale can move fast, but not everything you lose is fat. Body-composition research shows that a meaningful share of the weight lost during rapid reduction can come from lean tissue, including muscle. This guide explains where urolithin A fits as a muscle-quality support option, what the human evidence actually shows, and what is still preclinical.

Why muscle quality is worth protecting on a GLP-1 program

GLP-1 receptor agonists such as semaglutide and tirzepatide reduce appetite and produce substantial weight loss. Because the body sheds weight quickly, part of what is lost is lean mass rather than fat alone. Systematic reviews and body-composition analyses have estimated that a notable fraction of total weight lost, often described in the range of roughly a quarter to a third, can come from lean tissue, though estimates vary widely by study population, medication, dose, and how body composition was measured. Some of that lean-mass change is expected with any significant weight loss, but muscle is metabolically valuable: it supports strength, everyday function, glucose handling, and resting energy use.

This is why clinicians who manage GLP-1 patients emphasize adequate dietary protein and regular resistance training as the foundation for preserving muscle during weight loss. Supplements do not replace those basics. Urolithin A is best understood as a possible add-on that targets the quality of muscle cells at the mitochondrial level, not a substitute for protein, training, or medical guidance.

What urolithin A actually is

Urolithin A (UA) is a gut postbiotic. When you eat foods rich in ellagitannins, such as pomegranates, walnuts, and certain berries, gut bacteria can convert those compounds into urolithin A. The catch is that only some people carry the microbiome needed to make meaningful amounts, which is one reason interest in supplementing UA directly has grown. Taking it as a finished ingredient bypasses the conversion lottery.

The mechanism researchers focus on is mitophagy, the cellular housekeeping process that identifies worn-out mitochondria and recycles them so cells can maintain a healthier, more efficient population of these energy-producing structures. Mitochondrial quality tends to decline with age and with periods of physical stress, and muscle is one of the most mitochondria-dense tissues in the body. UA is studied for its ability to support this recycling process, which is the throughline connecting its muscle and mitochondrial health research.

The human evidence on muscle (strongest first)

Here is the honest picture, organized from the most established human findings to the newest, and clearly separated from animal work.

Established human trials

Human: Singh and colleagues (Cell Reports Medicine, 2022) ran a four-month randomized trial in middle-aged adults using 500 mg and 1,000 mg daily arms and reported improvements in measures of muscle strength and exercise performance. Human: Liu, D'Amico and colleagues (JAMA Network Open, 2022) studied older adults over roughly four months and observed improvements in muscle endurance. Human: the first-in-human work by Andreux and colleagues (Nature Metabolism, 2019) established that UA is safe and well tolerated at doses up to 1,000 mg per day and produced a mitochondrial gene-expression signature in muscle, evidence that the compound engages the biology it is meant to target.

Newer human trials

Human: a 2024 randomized controlled trial published in the Journal of the International Society of Sports Nutrition looked at eight weeks of supplementation in resistance-trained men, extending the research into people who already train. Human: a 2025 trial in distance runners added data in a different, endurance-focused population. Together these suggest the muscle research is broadening beyond older and sedentary groups, though sample sizes remain modest and endpoints vary.

What is still preclinical

Preclinical: the foundational discovery work by Ryu and colleagues (Nature Medicine, 2016) showed that urolithin A induced mitophagy, extended lifespan in the worm C. elegans, and improved muscle function in rodents. This animal and model-organism research is what motivated the human trials, but findings in worms and mice do not automatically translate to people. It is fair to say UA has genuine human muscle data behind it while much of the deeper mechanistic and longevity narrative remains preclinical. A 2024 systematic review in Ageing Research Reviews concluded that the evidence for targeting aging with urolithin A in humans is still emerging.

How urolithin A fits alongside a GLP-1 plan

No published trial has tested urolithin A specifically in people taking GLP-1 medications, so anyone claiming it prevents GLP-1-related muscle loss is going beyond the evidence. What the research supports is narrower and still useful: UA is studied for supporting mitochondrial quality and measures of muscle strength and endurance in the general adult population. If your goal on a weight program is to hold on to muscle quality while you lose fat, the sensible stack is protein first, resistance training second, and a studied mitochondrial-support ingredient like UA as an optional third layer.

Practical notes: the human trials used 500 to 1,000 mg per day, with 1,000 mg at the top of the studied range. Benefits in the trials emerged over roughly two to four months of consistent use, so this is a daily habit, not a quick fix. For more on timing and expectations, see how long urolithin A takes to work and our overview of urolithin A for muscle.